Pharmaceutical Intermediates Market to 2027 - Global Analysis and Forecasts By Type (GMP, Non GMP); Applications (Antibiotics, Antipyretic analgesics, Vitamins, Others); Distribution Channel (Direct Sales, Distributor) and Geography
Report Code: TIPRE00005559 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. Pharmaceutical intermediates are used in the production of bulk drugs As well as for research and development purpose by various pharm and biopharma companies. Pharmaceutical intermediates are formed at the time of process of production or synthesis of active pharmaceutical ingredients.
MARKET DYNAMICS
The pharmaceutical intermediates market is anticipated to grow owing the driving key factor such as high prevalence of chronic disease, increase population across the world, raising healthcare expenditure, high demand of medicine impact on pharmaceutical and biopharmaceutical production, awareness related to healthcare and raising R& D in pharm others. In other hand, various players in the emerging market and government initiative will create lubricate growth opportunities for the market in forecast period.
MARKET SCOPE
The "Global Pharmaceutical intermediates market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of pharmaceutical intermediates with detailed market segmentation by type, application, distribution channel and geography. The global pharmaceutical intermediates market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading the pharmaceutical intermediates market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global pharmaceutical intermediates market is segmented on the basis of type, application and distribution channel. Based on type, the market is segmented as GMP and Non GMP. On the basis of applications, the global pharmaceutical intermediates market is antibiotics, antipyretic analgesics, vitamins and others. Based on the distribution channel the market is classify into direct sales and distributor.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pharmaceutical intermediates market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pharmaceutical intermediates market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pharmaceutical intermediates market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pharmaceutical intermediates market in these regions.
MARKET PLAYERS
The reports cover key developments in the pharmaceutical intermediates market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pharmaceutical intermediates market are anticipated to lucrative growth opportunities in the future with the rising demand for pharmaceutical intermediates market in the global market. Below mentioned is the list of few companies engaged in the pharmaceutical intermediates market.
The report also includes the profiles of key pharmaceutical intermediates market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. Pharmaceutical intermediates are used in the production of bulk drugs As well as for research and development purpose by various pharm and biopharma companies. Pharmaceutical intermediates are formed at the time of process of production or synthesis of active pharmaceutical ingredients.
MARKET DYNAMICS
The pharmaceutical intermediates market is anticipated to grow owing the driving key factor such as high prevalence of chronic disease, increase population across the world, raising healthcare expenditure, high demand of medicine impact on pharmaceutical and biopharmaceutical production, awareness related to healthcare and raising R& D in pharm others. In other hand, various players in the emerging market and government initiative will create lubricate growth opportunities for the market in forecast period.
MARKET SCOPE
The "Global Pharmaceutical intermediates market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of pharmaceutical intermediates with detailed market segmentation by type, application, distribution channel and geography. The global pharmaceutical intermediates market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading the pharmaceutical intermediates market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global pharmaceutical intermediates market is segmented on the basis of type, application and distribution channel. Based on type, the market is segmented as GMP and Non GMP. On the basis of applications, the global pharmaceutical intermediates market is antibiotics, antipyretic analgesics, vitamins and others. Based on the distribution channel the market is classify into direct sales and distributor.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pharmaceutical intermediates market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pharmaceutical intermediates market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pharmaceutical intermediates market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pharmaceutical intermediates market in these regions.
The reports cover key developments in the pharmaceutical intermediates market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pharmaceutical intermediates market are anticipated to lucrative growth opportunities in the future with the rising demand for pharmaceutical intermediates market in the global market. Below mentioned is the list of few companies engaged in the pharmaceutical intermediates market.
The report also includes the profiles of key pharmaceutical intermediates market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer, Inc
- Dishman Group
- Dextra Laboratories Limited
- Sanofi Winthrop Industrie S.A
- Vertellus Holdings LLC
- BASF SE
- Lianhetech
- Codexis
- Midas Pharma GmbH
- chiracon GmbH
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pharmaceutical Intermediates Market - By Type
1.3.2 Pharmaceutical Intermediates Market - By Applications
1.3.3 Pharmaceutical Intermediates Market - By Distribution Channel
1.3.4 Pharmaceutical Intermediates Market - By Region
1.3.4.1 by Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PHARMACEUTICAL INTERMEDIATES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PHARMACEUTICAL INTERMEDIATES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PHARMACEUTICAL INTERMEDIATES MARKET - GLOBAL MARKET ANALYSIS
6.1. PHARMACEUTICAL INTERMEDIATES - GLOBAL MARKET OVERVIEW
6.2. PHARMACEUTICAL INTERMEDIATES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PHARMACEUTICAL INTERMEDIATES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. GMP
7.3.1. Overview
7.3.2. GMP Market Forecast and Analysis
7.4. NON GMP
7.4.1. Overview
7.4.2. Non GMP Market Forecast and Analysis
8. PHARMACEUTICAL INTERMEDIATES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. ANTIBIOTICS
8.3.1. Overview
8.3.2. Antibiotics Market Forecast and Analysis
8.4. ANTIPYRETIC ANALGESICS
8.4.1. Overview
8.4.2. Antipyretic analgesics Market Forecast and Analysis
8.5. VITAMINS
8.5.1. Overview
8.5.2. Vitamins Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. PHARMACEUTICAL INTERMEDIATES MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. DIRECT SALES
9.3.1. Overview
9.3.2. Direct Sales Market Forecast and Analysis
9.4. DISTRIBUTOR
9.4.1. Overview
9.4.2. Distributor Market Forecast and Analysis
10. PHARMACEUTICAL INTERMEDIATES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pharmaceutical Intermediates Market Overview
10.1.2 North America Pharmaceutical Intermediates Market Forecasts and Analysis
10.1.3 North America Pharmaceutical Intermediates Market Forecasts and Analysis - By Type
10.1.4 North America Pharmaceutical Intermediates Market Forecasts and Analysis - By Applications
10.1.5 North America Pharmaceutical Intermediates Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Pharmaceutical Intermediates Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pharmaceutical Intermediates Market
10.1.6.1.1 United States Pharmaceutical Intermediates Market by Type
10.1.6.1.2 United States Pharmaceutical Intermediates Market by Applications
10.1.6.1.3 United States Pharmaceutical Intermediates Market by Distribution Channel
10.1.6.2 Canada Pharmaceutical Intermediates Market
10.1.6.2.1 Canada Pharmaceutical Intermediates Market by Type
10.1.6.2.2 Canada Pharmaceutical Intermediates Market by Applications
10.1.6.2.3 Canada Pharmaceutical Intermediates Market by Distribution Channel
10.1.6.3 Mexico Pharmaceutical Intermediates Market
10.1.6.3.1 Mexico Pharmaceutical Intermediates Market by Type
10.1.6.3.2 Mexico Pharmaceutical Intermediates Market by Applications
10.1.6.3.3 Mexico Pharmaceutical Intermediates Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Pharmaceutical Intermediates Market Overview
10.2.2 Europe Pharmaceutical Intermediates Market Forecasts and Analysis
10.2.3 Europe Pharmaceutical Intermediates Market Forecasts and Analysis - By Type
10.2.4 Europe Pharmaceutical Intermediates Market Forecasts and Analysis - By Applications
10.2.5 Europe Pharmaceutical Intermediates Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Pharmaceutical Intermediates Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pharmaceutical Intermediates Market
10.2.6.1.1 Germany Pharmaceutical Intermediates Market by Type
10.2.6.1.2 Germany Pharmaceutical Intermediates Market by Applications
10.2.6.1.3 Germany Pharmaceutical Intermediates Market by Distribution Channel
10.2.6.2 France Pharmaceutical Intermediates Market
10.2.6.2.1 France Pharmaceutical Intermediates Market by Type
10.2.6.2.2 France Pharmaceutical Intermediates Market by Applications
10.2.6.2.3 France Pharmaceutical Intermediates Market by Distribution Channel
10.2.6.3 Italy Pharmaceutical Intermediates Market
10.2.6.3.1 Italy Pharmaceutical Intermediates Market by Type
10.2.6.3.2 Italy Pharmaceutical Intermediates Market by Applications
10.2.6.3.3 Italy Pharmaceutical Intermediates Market by Distribution Channel
10.2.6.4 Spain Pharmaceutical Intermediates Market
10.2.6.4.1 Spain Pharmaceutical Intermediates Market by Type
10.2.6.4.2 Spain Pharmaceutical Intermediates Market by Applications
10.2.6.4.3 Spain Pharmaceutical Intermediates Market by Distribution Channel
10.2.6.5 United Kingdom Pharmaceutical Intermediates Market
10.2.6.5.1 United Kingdom Pharmaceutical Intermediates Market by Type
10.2.6.5.2 United Kingdom Pharmaceutical Intermediates Market by Applications
10.2.6.5.3 United Kingdom Pharmaceutical Intermediates Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pharmaceutical Intermediates Market Overview
10.3.2 Asia-Pacific Pharmaceutical Intermediates Market Forecasts and Analysis
10.3.3 Asia-Pacific Pharmaceutical Intermediates Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Pharmaceutical Intermediates Market Forecasts and Analysis - By Applications
10.3.5 Asia-Pacific Pharmaceutical Intermediates Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Pharmaceutical Intermediates Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pharmaceutical Intermediates Market
10.3.6.1.1 Australia Pharmaceutical Intermediates Market by Type
10.3.6.1.2 Australia Pharmaceutical Intermediates Market by Applications
10.3.6.1.3 Australia Pharmaceutical Intermediates Market by Distribution Channel
10.3.6.2 China Pharmaceutical Intermediates Market
10.3.6.2.1 China Pharmaceutical Intermediates Market by Type
10.3.6.2.2 China Pharmaceutical Intermediates Market by Applications
10.3.6.2.3 China Pharmaceutical Intermediates Market by Distribution Channel
10.3.6.3 India Pharmaceutical Intermediates Market
10.3.6.3.1 India Pharmaceutical Intermediates Market by Type
10.3.6.3.2 India Pharmaceutical Intermediates Market by Applications
10.3.6.3.3 India Pharmaceutical Intermediates Market by Distribution Channel
10.3.6.4 Japan Pharmaceutical Intermediates Market
10.3.6.4.1 Japan Pharmaceutical Intermediates Market by Type
10.3.6.4.2 Japan Pharmaceutical Intermediates Market by Applications
10.3.6.4.3 Japan Pharmaceutical Intermediates Market by Distribution Channel
10.3.6.5 South Korea Pharmaceutical Intermediates Market
10.3.6.5.1 South Korea Pharmaceutical Intermediates Market by Type
10.3.6.5.2 South Korea Pharmaceutical Intermediates Market by Applications
10.3.6.5.3 South Korea Pharmaceutical Intermediates Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pharmaceutical Intermediates Market Overview
10.4.2 Middle East and Africa Pharmaceutical Intermediates Market Forecasts and Analysis
10.4.3 Middle East and Africa Pharmaceutical Intermediates Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Pharmaceutical Intermediates Market Forecasts and Analysis - By Applications
10.4.5 Middle East and Africa Pharmaceutical Intermediates Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Pharmaceutical Intermediates Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pharmaceutical Intermediates Market
10.4.6.1.1 South Africa Pharmaceutical Intermediates Market by Type
10.4.6.1.2 South Africa Pharmaceutical Intermediates Market by Applications
10.4.6.1.3 South Africa Pharmaceutical Intermediates Market by Distribution Channel
10.4.6.2 Saudi Arabia Pharmaceutical Intermediates Market
10.4.6.2.1 Saudi Arabia Pharmaceutical Intermediates Market by Type
10.4.6.2.2 Saudi Arabia Pharmaceutical Intermediates Market by Applications
10.4.6.2.3 Saudi Arabia Pharmaceutical Intermediates Market by Distribution Channel
10.4.6.3 U.A.E Pharmaceutical Intermediates Market
10.4.6.3.1 U.A.E Pharmaceutical Intermediates Market by Type
10.4.6.3.2 U.A.E Pharmaceutical Intermediates Market by Applications
10.4.6.3.3 U.A.E Pharmaceutical Intermediates Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pharmaceutical Intermediates Market Overview
10.5.2 South and Central America Pharmaceutical Intermediates Market Forecasts and Analysis
10.5.3 South and Central America Pharmaceutical Intermediates Market Forecasts and Analysis - By Type
10.5.4 South and Central America Pharmaceutical Intermediates Market Forecasts and Analysis - By Applications
10.5.5 South and Central America Pharmaceutical Intermediates Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Pharmaceutical Intermediates Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pharmaceutical Intermediates Market
10.5.6.1.1 Brazil Pharmaceutical Intermediates Market by Type
10.5.6.1.2 Brazil Pharmaceutical Intermediates Market by Applications
10.5.6.1.3 Brazil Pharmaceutical Intermediates Market by Distribution Channel
10.5.6.2 Argentina Pharmaceutical Intermediates Market
10.5.6.2.1 Argentina Pharmaceutical Intermediates Market by Type
10.5.6.2.2 Argentina Pharmaceutical Intermediates Market by Applications
10.5.6.2.3 Argentina Pharmaceutical Intermediates Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PHARMACEUTICAL INTERMEDIATES MARKET, KEY COMPANY PROFILES
12.1. PFIZER, INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DISHMAN GROUP
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. DEXTRA LABORATORIES LIMITED
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SANOFI WINTHROP INDUSTRIE S.A.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. VERTELLUS HOLDINGS LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BASF SE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LIANHETECH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CODEXIS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MIDAS PHARMA GMBH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CHIRACON GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pharmaceutical Intermediates Market - By Type
1.3.2 Pharmaceutical Intermediates Market - By Applications
1.3.3 Pharmaceutical Intermediates Market - By Distribution Channel
1.3.4 Pharmaceutical Intermediates Market - By Region
1.3.4.1 by Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PHARMACEUTICAL INTERMEDIATES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PHARMACEUTICAL INTERMEDIATES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PHARMACEUTICAL INTERMEDIATES MARKET - GLOBAL MARKET ANALYSIS
6.1. PHARMACEUTICAL INTERMEDIATES - GLOBAL MARKET OVERVIEW
6.2. PHARMACEUTICAL INTERMEDIATES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PHARMACEUTICAL INTERMEDIATES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. GMP
7.3.1. Overview
7.3.2. GMP Market Forecast and Analysis
7.4. NON GMP
7.4.1. Overview
7.4.2. Non GMP Market Forecast and Analysis
8. PHARMACEUTICAL INTERMEDIATES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. ANTIBIOTICS
8.3.1. Overview
8.3.2. Antibiotics Market Forecast and Analysis
8.4. ANTIPYRETIC ANALGESICS
8.4.1. Overview
8.4.2. Antipyretic analgesics Market Forecast and Analysis
8.5. VITAMINS
8.5.1. Overview
8.5.2. Vitamins Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. PHARMACEUTICAL INTERMEDIATES MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. DIRECT SALES
9.3.1. Overview
9.3.2. Direct Sales Market Forecast and Analysis
9.4. DISTRIBUTOR
9.4.1. Overview
9.4.2. Distributor Market Forecast and Analysis
10. PHARMACEUTICAL INTERMEDIATES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pharmaceutical Intermediates Market Overview
10.1.2 North America Pharmaceutical Intermediates Market Forecasts and Analysis
10.1.3 North America Pharmaceutical Intermediates Market Forecasts and Analysis - By Type
10.1.4 North America Pharmaceutical Intermediates Market Forecasts and Analysis - By Applications
10.1.5 North America Pharmaceutical Intermediates Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Pharmaceutical Intermediates Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pharmaceutical Intermediates Market
10.1.6.1.1 United States Pharmaceutical Intermediates Market by Type
10.1.6.1.2 United States Pharmaceutical Intermediates Market by Applications
10.1.6.1.3 United States Pharmaceutical Intermediates Market by Distribution Channel
10.1.6.2 Canada Pharmaceutical Intermediates Market
10.1.6.2.1 Canada Pharmaceutical Intermediates Market by Type
10.1.6.2.2 Canada Pharmaceutical Intermediates Market by Applications
10.1.6.2.3 Canada Pharmaceutical Intermediates Market by Distribution Channel
10.1.6.3 Mexico Pharmaceutical Intermediates Market
10.1.6.3.1 Mexico Pharmaceutical Intermediates Market by Type
10.1.6.3.2 Mexico Pharmaceutical Intermediates Market by Applications
10.1.6.3.3 Mexico Pharmaceutical Intermediates Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Pharmaceutical Intermediates Market Overview
10.2.2 Europe Pharmaceutical Intermediates Market Forecasts and Analysis
10.2.3 Europe Pharmaceutical Intermediates Market Forecasts and Analysis - By Type
10.2.4 Europe Pharmaceutical Intermediates Market Forecasts and Analysis - By Applications
10.2.5 Europe Pharmaceutical Intermediates Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Pharmaceutical Intermediates Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pharmaceutical Intermediates Market
10.2.6.1.1 Germany Pharmaceutical Intermediates Market by Type
10.2.6.1.2 Germany Pharmaceutical Intermediates Market by Applications
10.2.6.1.3 Germany Pharmaceutical Intermediates Market by Distribution Channel
10.2.6.2 France Pharmaceutical Intermediates Market
10.2.6.2.1 France Pharmaceutical Intermediates Market by Type
10.2.6.2.2 France Pharmaceutical Intermediates Market by Applications
10.2.6.2.3 France Pharmaceutical Intermediates Market by Distribution Channel
10.2.6.3 Italy Pharmaceutical Intermediates Market
10.2.6.3.1 Italy Pharmaceutical Intermediates Market by Type
10.2.6.3.2 Italy Pharmaceutical Intermediates Market by Applications
10.2.6.3.3 Italy Pharmaceutical Intermediates Market by Distribution Channel
10.2.6.4 Spain Pharmaceutical Intermediates Market
10.2.6.4.1 Spain Pharmaceutical Intermediates Market by Type
10.2.6.4.2 Spain Pharmaceutical Intermediates Market by Applications
10.2.6.4.3 Spain Pharmaceutical Intermediates Market by Distribution Channel
10.2.6.5 United Kingdom Pharmaceutical Intermediates Market
10.2.6.5.1 United Kingdom Pharmaceutical Intermediates Market by Type
10.2.6.5.2 United Kingdom Pharmaceutical Intermediates Market by Applications
10.2.6.5.3 United Kingdom Pharmaceutical Intermediates Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pharmaceutical Intermediates Market Overview
10.3.2 Asia-Pacific Pharmaceutical Intermediates Market Forecasts and Analysis
10.3.3 Asia-Pacific Pharmaceutical Intermediates Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Pharmaceutical Intermediates Market Forecasts and Analysis - By Applications
10.3.5 Asia-Pacific Pharmaceutical Intermediates Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Pharmaceutical Intermediates Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pharmaceutical Intermediates Market
10.3.6.1.1 Australia Pharmaceutical Intermediates Market by Type
10.3.6.1.2 Australia Pharmaceutical Intermediates Market by Applications
10.3.6.1.3 Australia Pharmaceutical Intermediates Market by Distribution Channel
10.3.6.2 China Pharmaceutical Intermediates Market
10.3.6.2.1 China Pharmaceutical Intermediates Market by Type
10.3.6.2.2 China Pharmaceutical Intermediates Market by Applications
10.3.6.2.3 China Pharmaceutical Intermediates Market by Distribution Channel
10.3.6.3 India Pharmaceutical Intermediates Market
10.3.6.3.1 India Pharmaceutical Intermediates Market by Type
10.3.6.3.2 India Pharmaceutical Intermediates Market by Applications
10.3.6.3.3 India Pharmaceutical Intermediates Market by Distribution Channel
10.3.6.4 Japan Pharmaceutical Intermediates Market
10.3.6.4.1 Japan Pharmaceutical Intermediates Market by Type
10.3.6.4.2 Japan Pharmaceutical Intermediates Market by Applications
10.3.6.4.3 Japan Pharmaceutical Intermediates Market by Distribution Channel
10.3.6.5 South Korea Pharmaceutical Intermediates Market
10.3.6.5.1 South Korea Pharmaceutical Intermediates Market by Type
10.3.6.5.2 South Korea Pharmaceutical Intermediates Market by Applications
10.3.6.5.3 South Korea Pharmaceutical Intermediates Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pharmaceutical Intermediates Market Overview
10.4.2 Middle East and Africa Pharmaceutical Intermediates Market Forecasts and Analysis
10.4.3 Middle East and Africa Pharmaceutical Intermediates Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Pharmaceutical Intermediates Market Forecasts and Analysis - By Applications
10.4.5 Middle East and Africa Pharmaceutical Intermediates Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Pharmaceutical Intermediates Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pharmaceutical Intermediates Market
10.4.6.1.1 South Africa Pharmaceutical Intermediates Market by Type
10.4.6.1.2 South Africa Pharmaceutical Intermediates Market by Applications
10.4.6.1.3 South Africa Pharmaceutical Intermediates Market by Distribution Channel
10.4.6.2 Saudi Arabia Pharmaceutical Intermediates Market
10.4.6.2.1 Saudi Arabia Pharmaceutical Intermediates Market by Type
10.4.6.2.2 Saudi Arabia Pharmaceutical Intermediates Market by Applications
10.4.6.2.3 Saudi Arabia Pharmaceutical Intermediates Market by Distribution Channel
10.4.6.3 U.A.E Pharmaceutical Intermediates Market
10.4.6.3.1 U.A.E Pharmaceutical Intermediates Market by Type
10.4.6.3.2 U.A.E Pharmaceutical Intermediates Market by Applications
10.4.6.3.3 U.A.E Pharmaceutical Intermediates Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pharmaceutical Intermediates Market Overview
10.5.2 South and Central America Pharmaceutical Intermediates Market Forecasts and Analysis
10.5.3 South and Central America Pharmaceutical Intermediates Market Forecasts and Analysis - By Type
10.5.4 South and Central America Pharmaceutical Intermediates Market Forecasts and Analysis - By Applications
10.5.5 South and Central America Pharmaceutical Intermediates Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Pharmaceutical Intermediates Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pharmaceutical Intermediates Market
10.5.6.1.1 Brazil Pharmaceutical Intermediates Market by Type
10.5.6.1.2 Brazil Pharmaceutical Intermediates Market by Applications
10.5.6.1.3 Brazil Pharmaceutical Intermediates Market by Distribution Channel
10.5.6.2 Argentina Pharmaceutical Intermediates Market
10.5.6.2.1 Argentina Pharmaceutical Intermediates Market by Type
10.5.6.2.2 Argentina Pharmaceutical Intermediates Market by Applications
10.5.6.2.3 Argentina Pharmaceutical Intermediates Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PHARMACEUTICAL INTERMEDIATES MARKET, KEY COMPANY PROFILES
12.1. PFIZER, INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DISHMAN GROUP
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. DEXTRA LABORATORIES LIMITED
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SANOFI WINTHROP INDUSTRIE S.A.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. VERTELLUS HOLDINGS LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BASF SE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LIANHETECH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CODEXIS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MIDAS PHARMA GMBH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CHIRACON GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Pfizer, Inc
2. Dishman Group
3. Dextra Laboratories Limited
4. Sanofi Winthrop Industrie S.A
5. Vertellus Holdings LLC
6. BASF SE
7. Lianhetech
8. Codexis
9. Midas Pharma GmbH
10. chiracon GmbH.
1. Pfizer, Inc
2. Dishman Group
3. Dextra Laboratories Limited
4. Sanofi Winthrop Industrie S.A
5. Vertellus Holdings LLC
6. BASF SE
7. Lianhetech
8. Codexis
9. Midas Pharma GmbH
10. chiracon GmbH.